Harpoon Therapeutics Presents Preclinical Data for TriTAC-XR Platform that Supports Potential for Improved Safety by Minimizing Cytokine Release Syndrome
12th April 2022
Portfolio
This post references, or is about Harpoon. Find out more by clicking below